Scholars@Duke
Miloni Shah

Selected Publications

Outcomes of Patients With New Left Bundle Branch Block After TAVR: TVT Registry Insights.

Journal Article Circ Cardiovasc Interv · February 2026 BACKGROUND: Cardiac conduction disturbances remain the most frequent complication of transcatheter aortic valve replacement (TAVR), but the clinical implications of new left bundle branch block (LBBB) after TAVR remain controversial. Here, we aim to assess ... Full text Link to item Cite

Out-of-Hospital 30-Day Mortality After Mitral TEER: Insights From the STS/ACC TVT Registry.

Journal Article JACC Cardiovasc Interv · April 14, 2025 BACKGROUND: Transcatheter edge-to-edge repair of mitral valve (mTEER) is increasingly being adopted, with improved outcomes. However, it remains crucial to evaluate short-term out-of-hospital mortality to elucidate areas for further improvement. OBJECTIVES ... Full text Link to item Cite

Temporal Changes in Procedural Success and Clinical Outcomes of MTEER by Mechanism of MR: Analysis of the STS/TVT Registry.

Journal Article Circ Cardiovasc Interv · March 2025 BACKGROUND: With the expansion of indications for mitral transcatheter edge-to-edge repair into nondegenerative etiologies, it is unknown whether changes in technical success and clinical outcomes have occurred. METHODS: The Society of Thoracic Surgeons/Am ... Full text Link to item Cite

Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis.

Journal Article CHEST Crit Care · December 2024 BACKGROUND: Coronavirus disease 2019 (COVID-19) pneumonia requires considerable healthcare resources. RESEARCH OBJECTIVE: Examine if a single dose of infliximab or abatacept, in addition to remdesivir and steroids, decreased resource utilization among part ... Full text Link to item Cite

Mitral Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation With Preserved Left Ventricular Function.

Journal Article JACC Cardiovasc Interv · November 11, 2024 BACKGROUND: Outcomes of mitral transcatheter edge-to-edge repair (MTEER) in patients with secondary mitral regurgitation (sMR) and preserved left ventricular ejection fraction (LVEF) are uncertain. OBJECTIVES: This study sought to describe outcomes of MTEE ... Full text Link to item Cite

Trends, Predictors, and Outcomes of Bleeding Complications After Mitral Transcatheter Edge-to-Edge Repair: TVT Registry Insights.

Journal Article JACC Cardiovasc Interv · October 28, 2024 BACKGROUND: Bleeding events after arterial transcatheter procedures are associated with increased morbidity and mortality. The frequency and clinical implications of bleeding after mitral transcatheter edge-to-edge repair (M-TEER) have not been well-studie ... Full text Link to item Cite

Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry.

Journal Article Circ Cardiovasc Interv · December 2023 BACKGROUND: Atherosclerotic cardiovascular disease is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Polyvascular disease (PVD), defined as involvement of ≥2 vascular beds (VBs), that is, ... Full text Link to item Cite

Heart failure medical therapy prior to mitral transcatheter edge-to-edge repair: the STS/ACC Transcatheter Valve Therapy Registry.

Journal Article Eur Heart J · November 21, 2023 BACKGROUND AND AIMS: Guideline-directed medical therapy (GDMT) is recommended before mitral valve transcatheter edge-to-edge repair (MTEER) in patients with heart failure (HF) and severe functional mitral regurgitation (FMR). Whether MTEER is being perform ... Full text Link to item Cite